Skip to content

Clinical trials

Terminated Lung Diseases, Interstitial trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Diseases, Interstitial Status: Terminated Clear all

36 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20071
20081
20102
20114
20121
20151
20163
20172
20182
20192
20206
20214
20221
20232
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated36

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Celgene3
Kyntra Bio2
University of New Mexico2
Assistance Publique - Hôpitaux de Paris1
AstraZeneca1
Boehringer Ingelheim1
Columbia University1
Corewell Health East1
Diffusion Pharmaceuticals Inc1
Duke University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Diseases, Interstitial36
Pulmonary Fibrosis11
Pulmonary Disease, Chronic Obstructive8
Idiopathic Pulmonary Fibrosis7
Lung Diseases5
Fibrosis4
Hypertension, Pulmonary4
Scleroderma, Systemic4
Asthma3
Idiopathic Interstitial Pneumonias3

Trials

Showing 1 to 25 of 36. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.